KEGG   DRUG: Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxilHelp
Entry
D10756            Mixture   Drug                                   

Name
Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil;
Stribild (TN)
Product
Component
Elvitegravir [DR:D06677], Cobicistat [DR:D09881], Emtricitabine [DR:D01199], Tenofovir disoproxil fumarate [DR:D01982]
Remark
Therapeutic category: 6250
ATC code: J05AR09
Product: D10756<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Comment
Elvitegravir and cobicistat are metabolized by CYP3A.
Cobicistat is also metabolized, to a minor extent, by CYP2D6.
Elvitegravir is a modest inducer of CYP2C9.
Cobicistat is an inhibitor of CYP3A and CYP2D6, and it is an inhibitor of the following transporters: P-gp, BCRP, OATP1B1 and OATP1B3. It is metabolized by OCT2.
Tenofovir disoproxil fumarate is modest inhibitor of CYP1A2.
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR09 Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
      D10756  Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Agents, Integrase Inhibitors (INSTI)
   Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate
    D10756  Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D10756  Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil
Antiinfectives [br08350.html]
 Antivirals
  D10756
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D10756
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10756
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10756
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10756
BRITE hierarchy
Other DBs
PubChem: 273220352
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system